Zobrazeno 1 - 10
of 309
pro vyhledávání: '"A, Kalykaki"'
Publikováno v:
In Mechanisms of Ageing and Development December 2024 222
Autor:
Gouvas Nikolaos, Kalambaliki Telenia, Voutsina Alexandra, Saridaki Zenia, Tzardi Maria, Kalykaki Aristea, Sfakianaki Maria, Athanasiadis Athanasios, Xynos Evaghelos, Boukovinas Ioannis, Souglakos John
Publikováno v:
Forum of Clinical Oncology, Vol 9, Iss 1, Pp 31-36 (2019)
Several studies show that mutational profiles could influence treatment decisions in patients with metastatic CRC (mCRC). KRAS mutational status was the first step in biomarkers development in the era of molecular targeted therapies. Recently, NRAS m
Externí odkaz:
https://doaj.org/article/bd9b256a7b0e4313a8fa70133728181b
Autor:
Panagiotis Tirchas, Evangelos Pilios, Minas Achladianakis, Christina Kalafati Matthaiou, George Kossioris, Argyri Kyriakaki, Eleftherios Avgenikou, Panagiotis Paraschis, Maria Kalykaki, Nicholas Christakis, Michael Politis
Publikováno v:
International Journal of Neural Networks and Advanced Applications. 8:12-26
Covid-19 is the most recent strain from the corona virus family that its rapid spread across the globe has caused a pandemic, resulting in over 200,000,000 infections and over 4,000,000 deaths so far. Many countries had to impose full lockdowns, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8be1e7934f4318fe420a0b4a62b72b17
https://doi.org/10.46300/91016.2021.8.3
https://doi.org/10.46300/91016.2021.8.3
Autor:
Drakoulis Yannoukakos, Despoina Kalfakakou, Nikolaos Androulakis, Paraskevi Apostolou, Sofia Agelaki, Elias Sanidas, Antonia Kalykaki, Christos Papadimitriou, Vassilis Georgoulias, Konstantinos Kalbakis, Lambros Vamvakas, Christos Christodoulou, Charalambos Kouroussis, Dimitris Mavroudis, Florentia Fostira, Irene Konstantopoulou, Angeliki Delimitsou, Emmanouil Saloustros
Publikováno v:
International Journal of Cancer. 147:1334-1342
Germline BRCA1 and BRCA2 loss-of-function variants have been linked to increased breast and ovarian cancer risk, with more than 5,000 distinct pathogenic variants being reported worldwide. Among individuals of Greek descent, the BRCA1/2 variant spect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc65d4db478ffe4347c7e147a3269b24
https://doi.org/10.1002/ijc.32903
https://doi.org/10.1002/ijc.32903
Autor:
Pallis, A.G. *, Karampeazis, A., Vamvakas, L., Vardakis, N., Kotsakis, A., Bozionelou, V., Kalykaki, A., Hatzidaki, D., Mavroudis, D., Georgoulias, V.
Publikováno v:
In Annals of Oncology November 2011 22(11):2448-2455
Autor:
Sofia Agelaki, Antonia Kalykaki, Harris Markomanolaki, Maria A Papadaki, Galatea Kallergi, Dora Hatzidaki, Kostas Kalbakis, Dimitrios Mavroudis, Vassilis Georgoulias
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0123683 (2015)
To evaluate the efficacy of lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, in therapy-resistant HER2-positive CTCs in metastatic breast cancer (MBC).Patients with MBC and HER2-positive CTCs despite disease stabilization or response to pri
Externí odkaz:
https://doaj.org/article/cd3e9bf174ff4b51adb459ccbc06d601
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
K. Yiangou, A. Hadjisavvas, S. Agelaki, D. Aggouraki, N. Androulakis, V. Bozionelou, I. Drositis, K. Kalmpakis, A. Kalykaki, E. Kontopodis, A. Kotsakis, E. Politaki, G. Saloustrou, L. Vamvakas, N.K. Vardakis, V. Georgoulias, D. Mavroudis, K. Michailidou, E. Saloustros
Publikováno v:
Annals of Oncology. 33:S189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e7d2dd263b48ee7dcb93aa3444e471f
https://doi.org/10.1016/j.annonc.2022.03.166
https://doi.org/10.1016/j.annonc.2022.03.166
Autor:
Pallis, A.G., Agelaki, S., Kakolyris, S., Kotsakis, A., Kalykaki, A., Vardakis, N., Papakotoulas, P., Agelidou, A., Geroyianni, A., Agelidou, M., Hatzidaki, D., Mavroudis, D., Georgoulias, V.
Publikováno v:
In Lung Cancer 2008 62(3):356-363
Autor:
Zacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, Chara Papadaki, Alexandra Voutsina, Aristea Kalykaki, Ippokratis Messaritakis, Kyriakos Mpananis, Dimitris Mavroudis, Efstathios Stathopoulos, Vassilis Georgoulias, John Souglakos
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84604 (2013)
To prospectively evaluate the usefulness of the BRAFV600E mutation detection in daily clinical practice in patients with metastatic Colorectal Cancer (mCRC).504 mCRC patients treated with systemic chemotherapy ± biologics were analyzed.A statistical
Externí odkaz:
https://doaj.org/article/faf485e051214337b50157574e0a3a05